The study, the biggest of its kind, was led by Professor Julia Hippisley-Cox in the University’s Division of Primary Care. It looked at prescribing patterns for over 9,000 patients aged between 25 and 100 across England, Scotland and Wales. The data came from the QRESEARCH database, run by the University in collaboration with the leading IT software provider EMIS. The online version of the BMJ paper was accessed 42,505 times in the first year after publication. It received 28 rapid responses and was cited 97 times in 2005 and 2006.
At the time there was widespread interest in the cardiovascular safety of COX 2 inhibitors after the withdrawal of Vioxx and several papers were published on the risk associated with these agents. The results have since been replicated in other countries by other academic teams.
Trish Groves, Deputy and Senior Research Editor at the BMJ, said: “Most of the papers in the top 10 provided important new evidence on highly controversial questions that mattered then to patients — and still do”. Several were about the safety and effectiveness of widely used treatments for common conditions, she noted. “These studies provide a broader kind of evidence: by systematically reviewing and summarising the best data out there, or analysing what really happened to large numbers of people in real life over time.”
Professor Julia Hippisley-Cox said “This is excellent news not least for the many thousands of GPs who have contributed to QRESEARCH by freely sharing their data to be used for medical research. We will continue to pioneer research into the real risks and benefits for treatments in primary care to give GPs the best information to improve clinical care for the individual patient.”
Dr David Stables, clinical director of EMIS, said “The ethical and non-commercial use of information makes QRESEARCH a worthwhile project that can make a significant difference to healthcare. We are very grateful to the practices who continue to take part in this project“
The study found that for those prescribed NSAIDS in the three months before the heart attack, the risk increased compared with those who had not taken these drugs in the previous three years. For ibruprofen, the risk increased by almost a quarter (24 per cent) and for diclofenac it rose by more than half (55 per cent)
The newer generation of painkillers — COX-2 inhibitors — were also associated with the increased rates of first-time heart attack. Those prescribed the drugs in the proceeding three months were at 21 per cent higher risk of heart attack if taking celecoxib, and 32 per cent increased risk if taking rofecoxib.
Emma Thorne | alfa
Some brain tumors may respond to immunotherapy, new study suggests
11.12.2018 | Columbia University Irving Medical Center
Climate change and air pollution damaging health and causing millions of premature deaths
30.11.2018 | International Institute for Applied Systems Analysis (IIASA)
A widely used diabetes medication combined with an antihypertensive drug specifically inhibits tumor growth – this was discovered by researchers from the University of Basel’s Biozentrum two years ago. In a follow-up study, recently published in “Cell Reports”, the scientists report that this drug cocktail induces cancer cell death by switching off their energy supply.
The widely used anti-diabetes drug metformin not only reduces blood sugar but also has an anti-cancer effect. However, the metformin dose commonly used in the...
A research team from the University of Zurich has developed a new drone that can retract its propeller arms in flight and make itself small to fit through narrow gaps and holes. This is particularly useful when searching for victims of natural disasters.
Inspecting a damaged building after an earthquake or during a fire is exactly the kind of job that human rescuers would like drones to do for them. A flying...
Over the last decade, there has been much excitement about the discovery, recognised by the Nobel Prize in Physics only two years ago, that there are two types...
What if a sensor sensing a thing could be part of the thing itself? Rice University engineers believe they have a two-dimensional solution to do just that.
Rice engineers led by materials scientists Pulickel Ajayan and Jun Lou have developed a method to make atom-flat sensors that seamlessly integrate with devices...
Scientists at the University of Stuttgart and the Karlsruhe Institute of Technology (KIT) succeed in important further development on the way to quantum Computers.
Quantum computers one day should be able to solve certain computing problems much faster than a classical computer. One of the most promising approaches is...
12.12.2018 | Event News
10.12.2018 | Event News
06.12.2018 | Event News
12.12.2018 | Health and Medicine
12.12.2018 | Physics and Astronomy
12.12.2018 | Health and Medicine